{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:18:09Z","timestamp":1777652289771,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Little is known on the burden of co-infections and superinfections in a specific setting such as the respiratory COVID-19 sub-intensive care unit. This study aims to (i) assess the prevalence of concurrent and superinfections in a respiratory sub-intensive care unit, (ii) evaluate the risk factors for superinfections development and (iii) assess the impact of superinfections on in-hospital mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Single-center retrospective analysis of prospectively collected data including COVID-19 patients hospitalized in a newly established respiratory sub-intensive care unit managed by pneumologists which has been set up from September 2020 at a large (1200 beds) University Hospital in Rome. Inclusion criteria were: (i) COVID-19 respiratory failure and\/or ARDS; (ii) hospitalization in respiratory sub-intensive care unit and (iii) age\u2009&gt;\u200918\u00a0years. Survival was analyzed by Kaplan\u2013Meier curves and the statistical significance of the differences between the two groups was assessed using the log-rank test. Multivariable logistic regression and Cox regression model were performed to tease out the independent predictors for superinfections\u2019 development and for mortality, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 201 patients were included. The majority (106, 52%) presented severe COVID-19. Co-infections were 4 (1.9%), whereas 46 patients (22%) developed superinfections, mostly primary bloodstream infections and pneumonia. In 40.6% of cases, multi-drug resistant pathogens were detected, with carbapenem-resistant <jats:italic>Acinetobacter baumannii<\/jats:italic> (CR-Ab) isolated in 47%. Overall mortality rate was 30%. Prior (30-d) infection and exposure to antibiotic therapy were independent risk factors for superinfection development whereas the development of superinfections was an independent risk factors for in-hospital mortality. <jats:italic>CR-Ab<\/jats:italic> resulted independently associated with 14-d mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In a COVID-19 respiratory sub-intensive care unit, superinfections were common and represented an independent predictor of mortality. CR-Ab infections occurred in almost half of patients and were associated with high mortality. Infection control rules and antimicrobial stewardship are crucial in this specific setting to limit the spread of multi-drug resistant organisms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02315-9","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T02:26:33Z","timestamp":1674267993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome"],"prefix":"10.1186","volume":"23","author":[{"given":"Alessandra","family":"Iacovelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Siccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Tramontano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio Maria","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Palange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"2315_CR1","unstructured":"WHO\u2014World Health Organization. https:\/\/covid19.who.int\/."},{"issue":"2","key":"2315_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cmi.2021.11.007","volume":"28","author":"M Bartoletti","year":"2022","unstructured":"Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Pa\u00f1o-Pardo JR, Power NR, Sibani M, Szabo BG, Tsiodras S, Verweij PE, Zollner-Schwetz I, Rodr\u00edguez-Ba\u00f1o J. ESCMID COVID-19 living guidelines: drug treatment and clinical management. Clin Microbiol Infect. 2022;28(2):222\u201338. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.007.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2315_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MCP.0000000000000666","volume":"26","author":"FW Arnold","year":"2020","unstructured":"Arnold FW, Fuqua JL. Viral respiratory infections: a cause of community-acquired pneumonia or a predisposing factor? Curr Opin Pulm Med. 2020;26(3):208\u201314. https:\/\/doi.org\/10.1097\/MCP.0000000000000666.","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"2315_CR4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","volume":"23","author":"DE Morris","year":"2017","unstructured":"Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;23(8):1041. https:\/\/doi.org\/10.3389\/fmicb.2017.01041.","journal-title":"Front Microbiol"},{"issue":"7","key":"2315_CR5","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10223","key":"2315_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"Lancet"},{"key":"2315_CR7","unstructured":"Chen J. COVID-19 scientific advisory group rapid response report 2020; May 6, 2020. Alberta Health Services."},{"key":"2315_CR8","doi-asserted-by":"crossref","unstructured":"WHO. Clinical management of COVID-19. World Health Organization. Interim guidance 27 May, 2020.","DOI":"10.15557\/PiMR.2020.0004"},{"issue":"7","key":"2315_CR9","doi-asserted-by":"publisher","first-page":"e12560","DOI":"10.15252\/emmm.202012560","volume":"12","author":"JA Bengoechea","year":"2020","unstructured":"Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7):e12560. https:\/\/doi.org\/10.15252\/emmm.202012560.","journal-title":"EMBO Mol Med"},{"key":"2315_CR10","doi-asserted-by":"publisher","unstructured":"Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128\u201340. https:\/\/doi.org\/10.1016\/0196-6553(88)90053-3. Erratum in: Am J Infect Control 1988;16(4):177.","DOI":"10.1016\/0196-6553(88)90053-3"},{"issue":"12","key":"2315_CR11","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.016.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"2315_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3201\/eid2704.204036","volume":"27","author":"A Patel","year":"2021","unstructured":"Patel A, Emerick M, Cabunoc MK, Williams MH, Preas MA, Schrank G, Rabinowitz R, Luethy P, Johnson JK, Leekha S. Rapid spread and control of multidrug-resistant gram-negative bacteria in COVID-19 patient care units. Emerg Infect Dis. 2021;27(4):1234\u20137. https:\/\/doi.org\/10.3201\/eid2704.204036.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2315_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s15010-021-01643-4","volume":"50","author":"A Russo","year":"2022","unstructured":"Russo A, Gavaruzzi F, Ceccarelli G, Borrazzo C, Oliva A, Alessandri F, Magnanimi E, Pugliese F, Venditti M. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022;50(1):83\u201392. https:\/\/doi.org\/10.1007\/s15010-021-01643-4.","journal-title":"Infection"},{"issue":"4","key":"2315_CR14","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/jac\/dkaa530","volume":"76","author":"M Falcone","year":"2021","unstructured":"Falcone M, Tiseo G, Giordano C, Leonildi A, Menichini M, Vecchione A, Pistello M, Guarracino F, Ghiadoni L, Forfori F, Barnini S, Menichetti F, Pisa COVID-19 Study Group. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother. 2021;76(4):1078\u201384. https:\/\/doi.org\/10.1093\/jac\/dkaa530.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2315_CR15","doi-asserted-by":"publisher","first-page":"e2021097","DOI":"10.23750\/abm.v92i2.11159","volume":"92","author":"C Deana","year":"2021","unstructured":"Deana C, Rovida S, Orso D, Bove T, Bassi F, De Monte A, Vetrugno L. Learning from the Italian experience during COVID-19 pandemic waves: be prepared and mind some crucial aspects. Acta Biomed. 2021;92(2):e2021097. https:\/\/doi.org\/10.23750\/abm.v92i2.11159.","journal-title":"Acta Biomed"},{"issue":"23","key":"2315_CR16","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526\u201333. https:\/\/doi.org\/10.1001\/jama.2012.5669.","journal-title":"JAMA"},{"key":"2315_CR17","unstructured":"WHO\u2014World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/clinical-care-of-severe-acute-respiratory-infections-tool-kit."},{"key":"2315_CR18","doi-asserted-by":"publisher","unstructured":"Langford BJ, So M, Simeonova M, Leung V, Lo J, Kan T, Raybardhan S et al. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. https:\/\/ssrn.com\/abstract=4099404 or https:\/\/doi.org\/10.2139\/ssrn.4099404.","DOI":"10.2139\/ssrn.4099404"},{"issue":"3","key":"2315_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2315_CR20","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, Klimko N, Lass-Fl\u00f6rl C, Oladele RO, Vinh DC, Zhu LP, B\u00f6ll B, Br\u00fcggemann R, Gangneux JP, Perfect JR, Patterson TF, Persigehl T, Meis JF, Ostrosky-Zeichner L, White PL, Verweij PE, Cornely OA, European Confederation of Medical Mycology; International Society for Human Animal Mycology; Asia Fungal Working Group; INFOCUS LATAM\/ISHAM Working Group; ISHAM Pan Africa Mycology Working Group; European Society for Clinical Microbiology; Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients; Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy; Medical Mycology Society of Nigeria; Medical Mycology Society of China Medicine Education Association; Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology; Association of Medical Microbiology; Infectious Disease Canada. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149\u201362. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1.","journal-title":"Lancet Infect Dis"},{"key":"2315_CR21","unstructured":"European Centre for Disease Prevention and Control. EU case definitions. https:\/\/www.ecdc.europa.eu\/en\/surveillance-and-disease-data\/eu-case-definitions. Retrieved 15 Dec 2022."},{"key":"2315_CR22","unstructured":"Centers for Disease Control and Prevention website. National Healthcare Safety Network (NHSN). Bloodstream Infection (BSI) Events. Available online: https:\/\/www.cdc.gov\/nhsn\/psc\/bsi\/index.html. Retrieved 15 Dec 2022."},{"key":"2315_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/infdis\/141.6.781","volume":"141","author":"DJ Cleri","year":"1980","unstructured":"Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis. 1980;141:781\u20136.","journal-title":"J Infect Dis"},{"issue":"9","key":"2315_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00134-020-06165-5","volume":"46","author":"L Kreitmann","year":"2020","unstructured":"Kreitmann L, Monard C, Dauwalder O, Simon M, Argaud L. Early bacterial co-infection in ARDS related to COVID-19. Intensive Care Med. 2020;46(9):1787\u20139. https:\/\/doi.org\/10.1007\/s00134-020-06165-5.","journal-title":"Intensive Care Med"},{"issue":"5","key":"2315_CR25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","volume":"40","author":"TW Rice","year":"2012","unstructured":"Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller RR, Higgs E, Randolph AG, Smoot BE, Thompson BT, NHLBI ARDS Network. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40(5):1487\u201398. https:\/\/doi.org\/10.1097\/CCM.0b013e3182416f23.","journal-title":"Crit Care Med"},{"issue":"1","key":"2315_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","volume":"27","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal C, Sanjuan G, Moreno-Garc\u00eda E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, Fernandez-Pittol M, Pitart C, Inciarte A, Bodro M, Morata L, Ambrosioni J, Grafia I, Meira F, Macaya I, Cardozo C, Casals C, Tellez A, Castro P, Marco F, Garc\u00eda F, Mensa J, Mart\u00ednez JA, Soriano A, COVID-19 Researchers Group. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.041.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2315_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s15010-020-01483-8","volume":"48","author":"A Oliva","year":"2020","unstructured":"Oliva A, Siccardi G, Migliarini A, Cancelli F, Carnevalini M, D\u2019Andria M, Attilia I, Danese VC, Cecchetti V, Romiti R, Ceccarelli G, Mastroianni CM, Palange P, Venditti M. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. 2020;48(6):871\u20137. https:\/\/doi.org\/10.1007\/s15010-020-01483-8.","journal-title":"Infection"},{"issue":"2","key":"2315_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266\u201375. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.046.","journal-title":"J Infect"},{"key":"2315_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nrmicro1789","volume":"5","author":"L Dijkshoorn","year":"2007","unstructured":"Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: Multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939\u201351. https:\/\/doi.org\/10.1038\/nrmicro1789.","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"2315_CR30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1164\/rccm.202106-1354OC","volume":"204","author":"CO Pickens","year":"2021","unstructured":"Pickens CO, Gao CA, Cuttica MJ, Smith SB, Pesce LL, Grant RA, Kang M, Morales-Nebreda L, Bavishi AA, Arnold JM, Pawlowski A, Qi C, Budinger GRS, Singer BD, Wunderink RG, NU COVID Investigators. Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. Am J Respir Crit Care Med. 2021;204(8):921\u201332. https:\/\/doi.org\/10.1164\/rccm.202106-1354OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2315_CR31","doi-asserted-by":"publisher","first-page":"e23687","DOI":"10.7759\/cureus.23687","volume":"14","author":"N Kurra","year":"2022","unstructured":"Kurra N, Woodard PI, Gandrakota N, Gandhi H, Polisetty SR, Ang SP, Patel KP, Chitimalla V, Ali Baig MM, Samudrala G. Opportunistic infections in COVID-19: a systematic review and meta-analysis. Cureus. 2022;14(3):e23687. https:\/\/doi.org\/10.7759\/cureus.23687.","journal-title":"Cureus"},{"issue":"4","key":"2315_CR32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","volume":"49","author":"WH Chong","year":"2021","unstructured":"Chong WH, Saha BK, Ramani A, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 2021;49(4):591\u2013605. https:\/\/doi.org\/10.1007\/s15010-021-01602-z.","journal-title":"Infection"},{"issue":"3","key":"2315_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cmi.2020.10.021","volume":"27","author":"M Ripa","year":"2021","unstructured":"Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, Muccini C, Monti G, De Luca G, Landoni G, Dagna L, Clementi M, Rovere Querini P, Ciceri F, Tresoldi M, Lazzarin A, Zangrillo A, Scarpellini P, Castagna A, COVID-BioB study group. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021;27(3):451\u20137. https:\/\/doi.org\/10.1016\/j.cmi.2020.10.021.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"2315_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00134-021-06495-y","volume":"47","author":"A Zanella","year":"2021","unstructured":"Zanella A, Florio G, Antonelli M, Bellani G, Berselli A, Bove T, Cabrini L, Carlesso E, Castelli GP, Cecconi M, Citerio G, Coloretti I, Corti D, Dalla Corte F, De Robertis E, Foti G, Fumagalli R, Girardis M, Giudici R, Guiotto L, Langer T, Mirabella L, Pasero D, Protti A, Ranieri MV, Rona R, Scudeller L, Severgnini P, Spadaro S, Stocchetti N, Vigan\u00f2 M, Pesenti A, Grasselli G, COVID-19 Italian ICU Network. Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units. Intensive Care Med. 2021;47(9):995\u20131008. https:\/\/doi.org\/10.1007\/s00134-021-06495-y.","journal-title":"Intensive Care Med"},{"issue":"2","key":"2315_CR35","doi-asserted-by":"publisher","first-page":"e22363","DOI":"10.7759\/cureus.22363","volume":"14","author":"I Bahceci","year":"2022","unstructured":"Bahceci I, Yildiz IE, Duran OF, Soztanaci US, KirdiHarbawi Z, Senol FF, Demiral G. Secondary bacterial infection rates among patients with COVID-19. Cureus. 2022;14(2):e22363. https:\/\/doi.org\/10.7759\/cureus.22363.","journal-title":"Cureus"},{"key":"2315_CR36","doi-asserted-by":"publisher","first-page":"e14937","DOI":"10.1097\/MD.0000000000014937","volume":"98","author":"H Zhou","year":"2019","unstructured":"Zhou H, Yao Y, Zhu B, Ren D, Yang Q, Fu Y, Yu Y, Zhou J. Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: a retrospective study from a Chinese hospital. Medicine. 2019;98:e14937. https:\/\/doi.org\/10.1097\/MD.0000000000014937.","journal-title":"Medicine"},{"key":"2315_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"2315_CR38","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3201\/eid2704.204036","volume":"27","author":"A Patel","year":"2021","unstructured":"Patel A, Emerick M, Cabunoc MK, et al. Rapid spread and control of multidrug-resistant Gram-negative bacteria in COVID-19 patient care units. Emerg Infect Dis. 2021;27:1234\u20137.","journal-title":"Emerg Infect Dis"},{"key":"#cr-split#-2315_CR39.1","unstructured":"US Centers for Disease Control and Prevention. COVID-19: U.S. impact on antimicrobial resistance, special report 2022 [Internet]. National Center for Emerging and Zoonotic Infectious Diseases"},{"key":"#cr-split#-2315_CR39.2","unstructured":"2022 Jun [cited 2022 Aug 9]. https:\/\/stacks.cdc.gov\/view\/cdc\/117915."},{"issue":"3","key":"2315_CR40","doi-asserted-by":"publisher","first-page":"dlac064","DOI":"10.1093\/jacamr\/dlac064","volume":"4","author":"M Falcone","year":"2022","unstructured":"Falcone M, Suardi LR, Tiseo G, Galfo V, Occhineri S, Verdenelli S, Ceccarelli G, Poli M, Merli M, Bavaro D, Carretta A, Nunnari G, Venanzi Rullo E, Trecarichi EM, Papalini C, Franco A, Del Vecchio RF, Bianco V, Punzi R, Francisci D, Rubino R, Torti C, Puoti M, Carbonara S, Cascio A, Saracino A, Santantonio T, Venditti M, Menichetti F. Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study). JAC Antimicrob Resist. 2022;4(3):dlac064. https:\/\/doi.org\/10.1093\/jacamr\/dlac064.","journal-title":"JAC Antimicrob Resist"},{"issue":"7","key":"2315_CR41","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/antibiotics11070926","volume":"11","author":"F Cogliati Dezza","year":"2022","unstructured":"Cogliati Dezza F, Arcari G, Alessi F, Valeri S, Curtolo A, Sacco F, Ceccarelli G, Raponi G, Alessandri F, Mastroianni CM, Venditti M, Oliva A. Clinical impact of COVID-19 on multi-drug-resistant gram-negative bacilli bloodstream infections in an intensive care unit setting: two pandemics compared. Antibiotics (Basel). 2022;11(7):926. https:\/\/doi.org\/10.3390\/antibiotics11070926.","journal-title":"Antibiotics (Basel)"},{"key":"2315_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13756-022-01052-8","volume":"11","author":"R Thoma","year":"2022","unstructured":"Thoma R, Seneghini M, Seiffert SN, Vuichard Gysin D, Scanferla G, Haller S, Flury D, Boggian K, Kleger G-R, Filipovic M, et al. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida Auris during the coronavirus disease 2019 pandemic: Report of a Carbapenem-Resistant Acinetobacter Baumannii Outbreak and a Systematic Review of the Literature. Antimicrob Resist Infect Control. 2022;11:12. https:\/\/doi.org\/10.1186\/s13756-022-01052-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"2315_CR43","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.infpip.2021.100113","volume":"3","author":"T Gottesman","year":"2021","unstructured":"Gottesman T, Fedorowsky R, Yerushalmi R, Lellouche J, Nutman A. An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital. Infect Prev Pract. 2021;3(1):100113. https:\/\/doi.org\/10.1016\/j.infpip.2021.100113.","journal-title":"Infect Prev Pract"},{"issue":"4","key":"2315_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1017\/ice.2021.144","volume":"43","author":"R Pascale","year":"2022","unstructured":"Pascale R, Bussini L, Gaibani P, Bovo F, Fornaro G, Lombardo D, Ambretti S, Pensalfine G, Appolloni L, Bartoletti M, Tedeschi S, Tumietto F, Lewis R, Viale P, Giannella M. Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: a multicenter before-and-after cross-sectional study. Infect Control Hosp Epidemiol. 2022;43(4):461\u20136. https:\/\/doi.org\/10.1017\/ice.2021.144.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"2315_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/pathogens10081006","volume":"10","author":"K Rangel","year":"2021","unstructured":"Rangel K, Chagas TPG, De-Simone SG. Acinetobacter baumannii infections in times of COVID-19 pandemic. Pathogens. 2021;10(8):1006. https:\/\/doi.org\/10.3390\/pathogens10081006.","journal-title":"Pathogens"},{"issue":"9","key":"2315_CR46","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1007\/s00134-019-05665-3","volume":"45","author":"A Jacquot","year":"2019","unstructured":"Jacquot A, Luyt CE, Kimmoun A, Levy B, Baux E, Fluvalentine Study group. Epidemiology of post-influenza bacterial pneumonia due to Panton-Valentine leucocidin positive Staphylococcus aureus in intensive care units: a retrospective nationwide study. Intensive Care Med. 2019;45(9):1312\u20134. https:\/\/doi.org\/10.1007\/s00134-019-05665-3.","journal-title":"Intensive Care Med"},{"issue":"5","key":"2315_CR47","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s15010-021-01624-7","volume":"49","author":"A Oliva","year":"2021","unstructured":"Oliva A, Ceccarelli G, Borrazzo C, Ridolfi M, Ettorre G, Alessandri F, Ruberto F, Pugliese F, Raponi GM, Russo A, Falletta A, Mastroianni CM, Venditti M. Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission. Infection. 2021;49(5):965\u201375. https:\/\/doi.org\/10.1007\/s15010-021-01624-7.","journal-title":"Infection"},{"issue":"9","key":"2315_CR48","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/myc.13292","volume":"64","author":"H Mitaka","year":"2021","unstructured":"Mitaka H, Kuno T, Takagi H, Patrawalla P. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis. Mycoses. 2021;64(9):993\u20131001. https:\/\/doi.org\/10.1111\/myc.13292.","journal-title":"Mycoses"},{"key":"2315_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","volume":"113","author":"WH Chong","year":"2021","unstructured":"Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021;113:115\u201329. https:\/\/doi.org\/10.1016\/j.jhin.2021.04.012.","journal-title":"J Hosp Infect"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02315-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02315-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02315-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T02:27:07Z","timestamp":1674268027000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02315-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2315"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02315-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"13 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. The study was approved by the local Ethics Committee of Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome (ID Prot. 109\/2020). The need for written informed consent was waived by the local Ethics Committee of Azienda Ospedaliera Universitaria Policlinico Umberto I due to retrospective nature of the study. However, at hospital admission, all the patients provided general consent for the use of their clinical data in future studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}